CYC vs ENL

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

CYC

CYCLOPHARM FPO [CYC]

41LOW

ENL

ENLITIC CDI FORUS [ENL]

36LOW

Score Breakdown

CYC ENL
Technical
41
42
Catalyst
51
60
Sentiment
50
50
Fundamental
69
37
Momentum
39
44
Risk Gate
50
19

Key Metrics

CYC Metric ENL
$61.6MMarket Cap$5.8M
345KAvg Volume (20d)4.1M
N/AShort Interest+0.1%
$1.29052-Week High$0.045
$0.45052-Week Low$0.004
-6.7%Daily Change+0.0%
$0.490Reference Price$0.007
-49.3%ROE-177.1%
-53.3%Profit MarginN/A

Active Signals

CYC Signals

●RSI drifting toward oversold territory — worth watching
●Volume surging at 2.7x normal while price falls — heavy selling pressure
●Watch out — volume is flowing out even as price holds up. Distribution pattern
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.5 quarters)
●Low P/S ratio (1.9x)
●Moderate revenue growth (+10%)
●EPS estimates revised upward (+10pts)

ENL Signals

●Volume surging at 2.1x normal while price falls — heavy selling pressure
●Beating the Small Ords index — relative strength of 1.25, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (0.9 quarters)
●Low P/S ratio (1.5x)
●Strong revenue growth (+118%)
●Piotroski F-Score weak (3/9, low-confidence approx)
●Near 52-week low (6% of range)

Ask Scout AI to compare CYC and ENL in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

CYC vs GSS →CYC vs IBX →CYC vs IMR →CYC vs MVF →CYC vs NEU →
CYC Full Analysis → ENL Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).